Effectiveness and Safety of the Levitan Scope for Laryngoscopy and Tracheal Intubation With a Simulated Difficult Airway
NCT ID: NCT01491984
Last Updated: 2015-03-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
105 participants
INTERVENTIONAL
2009-07-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Laryngoscopic View to Enable GlideScope-assisted Tracheal Intubation
NCT02144207
Comparison Study in Adult Surgical Patients of 5 Airway Devices
NCT00602979
A Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Tube Suction Disposable
NCT02884895
Comparison of the Macintosh, King Vision®, Glidescope® and AirTraq® Laryngoscopes in Routine Airway Management
NCT01914523
Videolaryngoscopes for Double Lumen Tube Intubations
NCT02305667
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In a small number of patients, the Levitan First Pass Success (FPS) Scope has been shown to be more effective and easier to insert even in patients who have difficult airways. This study will evaluate the use of the LFS compared to the other conventional laryngoscope in subjects with a simulated difficult airway. The goal of this study is to determine the effectiveness and safety of the LFS in a large number of patients with simulated airway difficulties.
The results obtained during the study may provide useful information to health care providers who cannot place a breathing tube in patients that are either in operating rooms or in emergency situations requiring intubation by paramedics. An example would be a trauma situation where a paramedic is having difficulty attempting an intubation when a patients c-spine is being protected from any movements.
The LFS is an affordable and transportable device, which makes this an attractive asset for health providers in smaller community settings or in paramedic vehicles which may not have the capacity to stock or ability to afford a variety of different scopes and must choose a more limited selection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laryngoscopy order: 1) MAC, 2) Levitan
Levitan FPS Intubation
Laryngoscopy order: 1) MAC, 2) Levitan
Laryngoscopy with MAC, then Levitan
Laryngoscopy order: 1) Levitan, 2) MAC
Laryngoscopy with Levitan, then MAC
Laryngoscopy order: 1) Levitan, 2) MAC
Macintosh Intubation
Laryngoscopy order: 1) MAC, 2) Levitan
Laryngoscopy with MAC, then Levitan
Laryngoscopy order: 1) Levitan, 2) MAC
Laryngoscopy with Levitan, then MAC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laryngoscopy order: 1) MAC, 2) Levitan
Laryngoscopy with MAC, then Levitan
Laryngoscopy order: 1) Levitan, 2) MAC
Laryngoscopy with Levitan, then MAC
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Elective surgery requiring endotracheal intubation
3. English speaking
4. Age 16 - 75 years
Exclusion Criteria
2. Prior history of a difficult intubation requiring an awake tracheal intubation
3. Clinical predictors of a potentially difficult intubation requiring an awake intubation
4. BMI \> 45 kg/m2 (Obesity is a common and important risk factor for difficult intubation)
16 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IWK Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ronald George
Primary Investigator, MD, FRCPC, Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronald B George, MD
Role: PRINCIPAL_INVESTIGATOR
IWK Health Centre
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IWK REB 4668
Identifier Type: OTHER
Identifier Source: secondary_id
IWK-4668-2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.